Molecular Diagnostics
Our diagnostic tests are used to identify biomarkers for leukemias, lymphomas, and other lymphoproliferative diseases. While most patients continue to be diagnosed and then lumped together for treatment as if they are
all afflicted by the identical disease, prognostic, predictive and pharmacodynamic biomarker testing stratifies disease, permitting physicians to tailor treatment for each individual patient. This helps ensure optimal treatment and the best possible outcome.
The goal of Personalized Molecular Medicine is to ensure patients receive: "the right medication, in the right amount, in the right form, at the right time, for the right disease.
Everyone's Disease is Different
We now know that everyone’s disease is different; both because the molecular basis of disease varies from one individual to another, and because the genetics of each individual are different. Accordingly, individuals metabolize and utilize (or often are unable to utilize) drugs that are routinely prescribed for these various diseases. Learn which diagnostic tests are available for your disease.
Accurate Prognosis and Treatment
Personalized molecular medicine is gaining acceptance because it has become apparent that for many drugs and diseases some relatively simple and cost-effective tests can stratify patients according to their disease status and genetics so they can get maximal benefit from treatment options.
This is the promise and the realization of Personalized Molecular Medicine and there are clear examples of the resounding success of this new and exciting field.